Experts in Europe are probing three newly reported conditions that appeared in people who received a COVID-19 vaccine built on messenger RNA, the European Union’s drug regulator said on Wednesday.
The safety panel of the European Medicines Agency (EMA) is reviewing post-vaccination cases of erythema multiforme, a skin condition that leaves people with round lesions; a type of kidney inflammation called glomerulonephritis; and nephrotic syndrome, a kidney disorder.
